Indegene Ltd, a healthcare tech firm focused on the global life sciences industry, on Monday said it has fixed the price band at Rs 430 to Rs 452 per share for its Rs 1,842-crore initial share-sale offer that opens for public subscription on May 6. The initial public offering (IPO) will conclude on May 8. The bidding for anchor investors will open for a day on May 3, the company announced.
The company’s IPO comprises a fresh issue of equity shares worth up to Rs 760 crore and an Offer For Sale (OFS) of up to 2.34 crore equity shares aggregating Rs 1,082 crore, at the higher end of the price band, by selling shareholders. This takes the total IPO size to 1,842 crore.
The OFS would see sale of shares by existing investors CA Dawn Investments, a Carlyle group entity, Vida Trustees in its capacity as partner of Group Life Spring, Brighton Park Capital’s entities BPC Genesis Fund I SPV Ltd, and BPC Genesis
Fund I-A SPV Ltd, and individual investors Manish Gupta, Rajesh Bhaskaran Nair, and Anita Nair.
